Julien Wegrzyn

Prof. Dr. Julien Wegrzyn

orcid

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 January 2021 in International Orthopaedics
Verified
Journal Article
Open access
PDF file
MPMichele Palazzuolo
Michele Palazzuolo
AAAlexander Antoniadis
Alexander Antoniadis
JMJaad Mahlouly
Jaad Mahlouly
JWJulien Wegrzyn
Julien Wegrzyn
Purpose: Total knee arthroplasty (TKA) is the treatment of choice for end-stage osteoarthritis though its risk-benefit ratio in elderly patients remains debated. This study aimed to evaluate the functional outcome, rates of complication and mortality, and quality-adjusted life years (QALY) in patients who exceeded their estimated life expectancy. Methods: Ninety-seven TKA implanted in 86 patients who exceeded their estimated life expectancy at the time of TKA were prospectively included in our institutional joint registry and retrospectively analyzed. At latest follow-up, the functional outcome with the Knee Society Score (KSS), rates of complication and mortality, and QALY with utility value of EuroQol-5D score were evaluated. Results: At a mean follow-up of three ± one years, the pre- to post-operative KSS improved significantly (p < 0.01). The rates of surgical and major medical complications related to TKA were 3% and 10%, respectively. The re-operation rate with readmission was 3% while no TKA was revised. The 30-day and one year mortality was 1% and 3%, respectively. The pre- to one year post-operative QALY improved significantly (p < 0.01). The cumulative QALY five years after TKA was four years. Assuming that these patients did not undergo TKA, their cumulative QALY at five years would have been only two years. Conclusion: TKA is an effective procedure for the treatment of end-stage osteoarthritis in patients who exceeded their estimated life expectancy. TKA provided significant improvement in function and quality of life without adversely affecting overall morbidity and mortality. Therefore, TKA should not be contra-indicated in elderly patients based on their advanced age alone.

12 January 2022 in International Orthopaedics
Verified
Journal Article
Open access
PDF file
JWJulien Wegrzyn
Julien Wegrzyn
AAAlexander Antoniadis
Alexander Antoniadis
ESEhsan Sarshari
Ehsan Sarshari
MBMatthieu Boubat
Matthieu Boubat
ATAlexandre Terrier
Alexandre Terrier
Purpose: Concerns remain about potential increased wear with dual mobility cups related to the multiple articulations involved in this specific design of implant. This finite element analysis study aimed to compare polyethylene (PE) wear between dual mobility cup and conventional acetabular component, and between the use of conventional ultra-high molecular weight PE (UHMWPE) and highly cross-linked PE (XPLE). Methods: Patient-specific finite element modeling was developed for 15 patients undergoing primary total hip arthroplasty (THA). Five acetabular components were 3D modeled and compared in THA constructs replicating existing implants: a dual mobility cup with a 22.2-mm-diameter femoral head against UHMWPE or XLPE (DM22PE or DM22XL), a conventional cup with a 22.2-mm-diameter femoral head against UHMWPE (SD22PE) and a conventional cup with a 32-mm-diameter femoral head against UHMWPE or XLPE (SD32PE or SD32XL). Results: DM22PE produced 4.6 times and 5.1 times more volumetric wear than SD32XL and DM22XL (p < 0.0001, Cohen’s d = 6.97 and 7.11; respectively). However, even if significant, the differences in volumetric wear between DM22XL and SD32XL as well as between DM22PE and SD22PE or SD32PE were small according to their effect size (p < 0.0001, Cohen’s |d|= 0.48 to 0.65) and could be therefore considered as clinically negligible. Conclusion: When using XLPE instead of UHMWPE, dual mobility cup with a 22.2-mm-diameter femoral head produced a similar amount of volumetric wear than conventional acetabular component with a 32-mm-diameter femoral head against XLPE. Therefore, XLPE is advocated in dual mobility cup to improve its wear performance.

13 November 2019 in Clinical Orthopaedics and Related Research
Verified
Journal Article
Closed access
JWJulien Wegrzyn
Julien Wegrzyn
MMMatthieu Malatray
Matthieu Malatray
VPVincent Pibarot
Vincent Pibarot
GAGaetano Anania
Gaetano Anania
JBJacques Béjui-Hugues
Jacques Béjui-Hugues
Background: Intraprosthetic dislocation is a specific complication of dual mobility cups, although it occurs less frequently with the latest generations of implants. Intraprosthetic dislocation is related to long-term polyethylene wear of the mobile component chamfer and retentive area, leading to a snap-out of the femoral head. With the increased use of dual mobility cups, even in younger and active patients, the management of intraprosthetic dislocation should be defined according to its type. However, no previous studies, except for case reports, have described the strategy to manage long-term wear-related intraprosthetic dislocation, particularly when a dual mobility cup is not loose. Questions/purposes: This study aimed to (1) determine the prevalence of intraprosthetic dislocation in this patient population and the macroscopic findings at the time of surgical revision and (2) evaluate whether isolated mobile component exchange could be an option to manage intraprosthetic dislocation occurring with a well-fixed dual mobility cup metal shell. Methods: From January 1991 to December 2009, a continuous series of 5274 THAs with dual mobility cups (4546 patients; 2773 women; mean [range] age 58 years [22-87]; bilateral THA = 728) were prospectively enrolled in our institutional total joint registry. A cementless, hemispherical dual mobility cup was systematically implanted, regardless of the patient’s age or indication for THA. At the latest follow-up examination, the registry was queried to isolate each occurrence of intraprosthetic dislocation, which was retrospectively analyzed regarding the patient’s demographics, indication for THA, radiographs, intraoperative findings (polyethylene wear and lesion patterns on the mobile component, periarticular metallosis, and implant damage because of intraprosthetic impingement of the femoral neck), management of intraprosthetic dislocation (isolated exchange of the mobile component or revision of the dual mobility cup), and outcome. Results: At a mean (range) follow-up duration of 14 years (3-26), 3% of intraprosthetic dislocations (169 of 5274) were reported, with a mean (range) time from THA of 18 years (13-22). Intraprosthetic dislocation occurred predominantly in younger men (mean [range] age at THA, 42 years [22-64] versus 61 years [46-87]; p < 0.001, and sex ratio (male to female, 1:32 [96 male and 73 female] versus 0.62 [1677 male and 2700 female]; p < 0.001) in patients with intraprosthetic dislocation and those without, respectively, but was not influenced by the indication for THA (105 patients with intraprosthetic dislocation who underwent THA for primary hip osteoarthritis and 64 with other diagnoses versus 3146 patients without who underwent THA for primary hip osteoarthritis and 1959 for other diagnoses (p = 0.9)). In all patients with intraprosthetic dislocation, a macroscopic analysis of the explanted mobile component revealed circumferential polyethylene wear and damage to the chamfer and retentive area, with subsequent loss of retaining power for the femoral head. Nine percent of intraprosthetic dislocations (16 of 169 patients with intraprosthetic dislocations) were associated with aseptic loosening of the dual mobility cup and were managed with acetabular revision without recurrence at a mean (range) follow-up duration of 7.5 years (5-11). Ninety-one percent of intraprosthetic dislocations (153 of 169) were pure, related to wear of the mobile component chamfer and retentive area without aseptic loosening of the dual mobility cup, and managed with isolated mobile component exchange. Intraprosthetic dislocation recurred in 6% (nine of 153) at a mean (range) follow-up interval of 3 years (2-4.5). Additionally, severe premature polyethylene wear of the mobile component with loosening of the dual mobility cup occurred in 12% of patients (19 of 153) at a mean (range) follow-up duration of 1.5 years (0.5-3). Conclusions: A failure rate of 18% (28 of 153 patients undergoing isolated mobile component exchange) was reported within 5 years after isolated mobile component exchange to manage intraprosthetic dislocation occurring with a well-fixed dual mobility cup metal shell. The two modes of failure were early recurrence of intraprosthetic dislocation or severe premature metallosis-related polyethylene wear of the mobile component with loosening of the dual mobility cup. Acetabular revision with synovectomy should remain the standard procedure to manage intraprosthetic dislocation, particularly if periarticular metallosis is present. The exception is intraprosthetic dislocation occurring in elderly or frail patients, for whom a conventional acetabular revision procedure would be associated with an unjustified surgical or anesthetic risk. Level of Evidence: Level II, prognostic study.

1 February 2022 in Nature and Science of Sleep
Verified
Journal Article
Open access
PDF file
PAProf. Dr. Eric Albrecht
Prof. Dr. Eric Albrecht
PPPedro Pereira
Pedro Pereira
VBVirginie Bayon
Virginie Bayon
MBMathieu Berger
Mathieu Berger
JWJulien Wegrzyn
Julien Wegrzyn
RHRaphael Heinzer
Raphael Heinzer
Purpose: Residual postoperative pain after hip arthroplasty is usually treated with oral opioids. While classic opioids are associated with respiratory depression and worsening of sleep apnea, tramadol has been reported to preserve respiratory function. However, this has not been investigated in a prospective trial using respiratory polygraphy. This randomized controlled triple-blinded trial tested the hypothesis that postoperative treatment with oral opioids such as oxycodone would increase sleep apnea severity, measured with a respiratory polygraphy, compared with oral tramadol. Patients and Methods: Sixty patients undergoing hip arthroplasty under spinal anesthesia with 15 mg isobaric bupivacaine 0.5% were randomized to receive postoperative pain treatment with either oral oxycodone (controlled-release 10 mg every 12 hours and immediate-release 5 mg every 4 hours as needed) or oral tramadol (controlled-release 100 mg every 8 hours and immediate-release 50 mg every 4 hours as needed). Respiratory polygraphy was performed on the first postoperative night. The primary outcome was the apnea-hypopnea index in the supine position. Secondary outcomes included the oxygen desaturation index, postoperative pain scores and intravenous morphine consumption. Results: Mean supine apnea-hypopnea index on postoperative night 1 was 11.3 events.h− 1 (95% confidence interval, 4.8– 17.7) in the oxycodone group and 10.7 (4.6– 16.8) events.h− 1 in the tramadol group (p=0.89). There were no significant differences between the oxycodone and tramadol groups with respect to any secondary sleep-related or pain-related outcomes. Conclusion: Oral oxycodone did not increase sleep apnea severity measured using respiratory polygraphy compared with oral tramadol on the first postoperative night after hip arthroplasty. Trial Registration Number: Clinicaltrials.gov – NCT03454217 (date of registration: 05/03/2018).

17 July 2024 in Orthopaedics & Traumatology: Surgery & Research
Verified
Journal Article
Open access
MMMarion Mutschler
Marion Mutschler
AMAllegra Massazza
Allegra Massazza
AAAlexander Antoniadis
Alexander Antoniadis
MPMichele Palazzuolo
Michele Palazzuolo
JWJulien Wegrzyn
Julien Wegrzyn
Along with the advent of newer bearings, hip resurfacing (HR) is gaining renewed interest as a bone sparing alternative to conventional total hip arthroplasty (THA) in young patients. However, the outcome of conversion of failed HR to THA (HRc) remains sparsely described. This study aimed to compare the outcomes and complication rates of HRc to those of primary (pTHA) and revision THA (rTHA) to find out to which group HRc is most comparable. The study hypothesis was that the outcomes and complications rates of HRc were closer to those of pTHA than rTHA. Between 2001 and 2011, a continuous series of 207 HR were prospectively included in our institutional registry and retrospectively analyzed. Out of them, 17 HR (8%) were converted to THA. Propensity scores were used to match patients in the HRc group to the pTHA and the rTHA groups using a greedy 1:3 matching procedure (51 pTHA and 51 rTHA). Clinical and radiographic outcomes, perioperative data and complications were analyzed and compared between the three groups. No significant difference between HRc and pTHA was observed in terms of clinical and functional outcomes, duration of surgery, acetabular component diameter and length of hospital stay (p = 0.13 to 0.94). Perioperative blood loss was significantly lower for pTHA than for HRc (p = 0.01). HRc demonstrated significantly higher HHS and HOOS scores than for rTHA at one year (p = 0.03 and p < 0.01, respectively). Duration of surgery was significantly lower in HRc compared to rTHA (p = 0.02) while length of hospital stay was similar (p = 0.84). Complication rate was significantly higher in the rTHA group, compared to HRc and pTHA groups (37.3 vs 29.4 vs 11.8%, p = 0.01). This study demonstrated that the clinical and functional outcomes of HRc were closer to those of pTHA than those of rTHA, though complication rate was higher than for pTHA. III; Retrospective comparative study.

15 July 2025 in Orthopaedics & Traumatology: Surgery & Research
Verified
Journal Article
Open access
NLNathan Lacheux
Nathan Lacheux
CBChristian Brand
Christian Brand
MBMartin Beck
Martin Beck
MKMaja Kägi
Maja Kägi
AAAlexander Antoniadis
Alexander Antoniadis
JWJulien Wegrzyn
Julien Wegrzyn
The optimal choice of the type of hip arthroplasty for managing acute femoral neck fractures (FNF) remains controversial, particularly when deciding between total hip arthroplasty (THA) and hemiarthroplasty (HA). Dual mobility cups (DM) have demonstrated efficacy in preventing instability, which is a potential concern with conventional THA. This study aimed to compare the outcomes of HA, DM, and conventional THA for managing FNF using data from a nationwide cohort collected through the Swiss National Joint Registry (SIRIS). Hemiarthroplasty has lower revision rates in older patients, while THA demonstrates lower revision rates in younger patients. Between 2012 and 2022, 37,169 patients who underwent hip arthroplasty for FNF in Switzerland were prospectively and systematically included in the SIRIS national registry. This cohort included 22,053 HA, 3,263 DM THA, and 11,853 conventional THA procedures. The study compared revision rates and implant survivorship for both septic and aseptic failures among these groups. Hazard ratios (HR) for revisions were calculated to compare HA, DM, and conventional THA, with subgroup analyses performed after adjusting for age, gender, BMI, and ASA scores. At the 10-year follow-up, the cumulative revision rates were 7.8% [6.4-9.4] for HA, 8.1% [7.6-10] for DM THA and 8.7% [7.7-9.9] for conventional THA. HA showed a trend toward a lower revision risk compared to DM and conventional THA (HR = 0.86 [95% CI: 0.72-1.02]), though this did not reach statistical significance. However, in patients <65 years, HA had a high 10-year revision rate of 20.7% [13.5-31.1], with 56.1% of these revisions involving conversion to THA. In addition, HA with cementless femoral stems had a significantly higher revision rate due to femoral periprosthetic fractures compared to cemented stems (HR = 1.81 [95% CI: 1.39-2.38]). Moreover, HA performed through a posterior approach had significantly higher revision rates due to dislocations compared to anterior approaches (HR = 1.64 [95% CI: 1.27-2.11]). When managing acute FNF with hip arthroplasty, there was no significant difference in revision rates or survivorship between HA, DM THA, and conventional THA at 10 years. However, for patients under 65 years, HA demonstrated a 20% revision rate over 10 years, with over half of these revisions involving conversion to THA. Based on these results, THA is recommended for younger patients, especially when life expectancy exceeds 10 years. For older patients, HA remains a viable option, provided certain technical considerations are followed i.e. the use of cemented femoral stems to reduce the risk of femoral periprosthetic fractures and the anterior approaches to minimize the risk of dislocation. These findings underlined the importance of tailoring arthroplasty choices to individual patient characteristics, including age, life expectancy, and surgical technique. III.